- August 27, 2019
- Posted by: admin
- Categories: Business Development, EduTainment,Senatormedical, Healthcare items, International, Medical Devices, Medisenator, New partners, New projects, Senator Medical AB
Oncology sponsored Article
Scalp cooling is a new approach to reduce chemotherapy-induced alopecia that has been used by patients worldwide for decades. Reduced temperature results in a reduced blood flow to the scalp area so that less chemotherapy reaches the hair cells. Therefore, hair cells are not exposed to the full dose of chemotherapy and may be able to survive the chemotherapy treatment. As a result, it is less likely to fall out.
How Scalp Cooling Works
Two physiologic reactions occur during scalp cooling:
1. Reduced blood flow
Vasoconstriction in the scalp area limits the amount of chemotherapy delivered to the hair follicles.
2. Reduced metabolism
Lower scalp temperature decreases the reaction rate of normal cellular activity in the localized scalp area to slow dramatically.
With these two reactions, the follicles are significantly reduced.
Why Scalp Cooling Matters
A patient’s hair can be a part of their identity, and one of the most devastating side effects of chemotherapy. Chemotherapy-induced alopecia is an unwelcome reminder of disease, one that can negatively affect self-image, confidence, overall sense of well-being and a patient’s attitude toward treatment.
Hair loss is no longer inevitable. The DigniCap Scalp Cooling System is an approach to reduce chemotherapy-induced alopecia, used successfully by patients worldwide to maintain their privacy, self-esteem and control during a critical period of treatment.